Discovery of levodopa-induced dyskinesia-associated genes using genomic studies in patients and Drosophila behavioral analyses

Although levodopa is the most effective medication for Parkinson’s disease, long-term levodopa treatment is largely compromised due to late motor complications, including levodopa-induced dyskinesia (LID). However, the genetic basis of LID pathogenesis has not been fully understood. Here, we discove...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Woongchang, Min, Soohong, Ryu, Ho-Sung, Chung, Sun Ju, Chung, Jongkyeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411113/
https://www.ncbi.nlm.nih.gov/pubmed/36008531
http://dx.doi.org/10.1038/s42003-022-03830-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411113/
https://www.ncbi.nlm.nih.gov/pubmed/36008531
http://dx.doi.org/10.1038/s42003-022-03830-x

Ejemplares similares